Study startup rarely fails loudly. It fails through accumulation: one status email, one duplicate data entry, one person out sick who holds all the context. By the time a site activation milestone flips from green to red, the window to fix it is already closed. That gap between appearance and reality is where activation delays actually originate, and a new analysis from Advarra’s team identifies the five workflow patterns that produce it.
The most corrosive pattern is the one that feels the most normal: teams spending meeting time reconstructing where work stands rather than resolving what’s blocked. When project leads depend on recurring check-ins and email chains to learn whether documents, contracts, or training activities are complete, communication volume is doing the job that a shared workflow should do. A related but distinct problem is duplicate information entry, where sites are asked to resend documents they’ve already provided, or milestone dates live in multiple spreadsheets with no authoritative source. Each redundant request creates another chance for conflicting versions and another reason sites deprioritize that sponsor’s requests when competing studies are waiting.
Two of the five warning signs concern resilience and visibility. If progress on a startup task stops when one person is unavailable, because context sits in an inbox or a personal spreadsheet, the workflow depends on individual access rather than shared ownership. The fix isn’t copying more people on emails; it’s documented decision rights and defined backup coverage. The visibility problem is subtler: a milestone dashboard that shows green while a prerequisite review hasn’t started, or an intermediate deadline is slipping, reports outcomes without showing the conditions that produce them. By the time the status turns red, Advarra’s framework argues, a meaningful intervention is no longer possible. Earlier awareness requires a small set of trackable sub-milestones tied to specific owners and escalation points, not just final due dates.
The fifth sign is the one sites feel most directly: sponsor processes organized around internal functions rather than around how sites actually work. When requests arrive from different contacts in different formats, sites absorb the coordination burden on top of contracting, ethics submissions, and patient-facing responsibilities. WCG Clinical’s benchmarking data shows activation timelines vary substantially by site type, and administrative overload is a documented driver of that variance. The concrete test for any startup team is whether a site can act on a request without first tracking down missing context or forwarding it to someone else.
Source link: https://www.advarra.com/blog/5-warning-signs-your-study-startup-workflow-needs-attention/
Moe Alsumidaie, MBA, MSF, is founder and Chief Editor of Vanguard Publications, which publishes Clinical Trial Vanguard, Pharma Vanguard and BullScope, and Head of Research at CliniBiz. He has two decades in clinical trial operations and data science, with earlier roles at Genentech, Abbott Vascular and Stanford University Medical Center, and is a guest lecturer in clinical trial sciences at Rutgers University.
